Sean D. Sullivan

faculty photo
The fertility of our minds to invent health care technology must now be matched by a commitment to assess and identify its appropriate use.
Professor, Health Services
Professor, Department of Pharmacy (primary appt.)
Adjunct Professor, Allergy and Infectious Dis.


PhD   University of California (Berkeley), 1992   (Health Economics)
MS   University of Texas (Austin), 1986   (Pharmacy)
BS   Oregon State University, 1983   (Pharmacy)

Contact Info


office:   H-375, Health Sciences Building

1959 NE Pacific Street
Seattle, WA 98195-7630

campus box:   357630
voice:   206-685-8153
fax:   206-543-3835


Sean D. Sullivan, BScPharm, MSc, PhD, is Professor and Dean of the University of Washington School of Pharmacy. He holds a joint appointment as Professor of Health Services in the School of Public Health. He also holds adjunct appointments in the School of Medicine, the Public Health Sciences Division at the Fred Hutchinson Cancer Research Center, and at Group Health Research Institute.

He completed his bachelor's degree in pharmacy from Oregon State University in 1983, master's degree in administrative and economic sciences from the University of Texas in 1986 and PhD in health economics and policy from the University of California-Berkeley in 1991.

Dr. Sullivan has authored more than 300 journal articles, book chapters, task force reports and organizational and governmental publications. In many of these writings, he has assessed the evidence and applications of medical technology in relation to coverage and reimbursement decisions. His research interests include technology assessment, medical decision-making and economic evaluation of medical technology. He is the past chair of the Academy of Managed Care Pharmacy executive committee on the AMCP Format for Formulary Submissions - the United States evidence-based guidelines for formulary decision-making.

Dr. Sullivan is a member of the Medicare Evidence Development and Coverage Advisory Committee. He is also on the editorial boards of Value in Health, PharmacoEconomics, European Journal of Health Economics and Core Evidence. He is a past president of the International Society for Pharmacoeconomics and Outcomes Research.

Technology assessment; medical decision making; economic evaluation of pharmaceuticals, particularly in the areas of respiratory disorders, organ transplantation, HIV/AIDS, mental health and clinical decision making

Bennette CS, Richards C, Sullivan SD, Ramsey SD. Steady Increase In Prices For Oral Anticancer Drugs After Market Launch Suggests A Lack Of Competitive Pressure. Health Aff (Millwood). 2016 May 1;35(5):805-12. doi: 10.1377/hlthaff.2015.1145.  PMID: 27140986

McDougall JA, Bansal A, Goulart BH, McCune JS, Karnopp A, Fedorenko C, Greenlee S, Valderrama A, Sullivan SD, Ramsey SD. The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone. Oncologist. 2016 Mar;21(3):320-6. doi: 10.1634/theoncologist.2015-0327. Epub 2016 Feb 10.  PMID: 26865591    PMCID: PMC4786354

Rundell SD, Goode AP, Friedly JL, Jarvik JG, Sullivan SD, Bresnahan BW. Role of Health Services Research in Producing High-Value Rehabilitation Care. Phys Ther. 2015 Dec;95(12):1703-11. doi: 10.2522/ptj.20150033. Epub 2015 Aug 27.  PMID: 26316531    PMCID: PMC4667153

Roth JA, Cohen JT, Veenstra DL, Chen E, Jhuti GS, Neumann PJ, Sullivan SD. Development of A Cost-Effectiveness Analysis Framework for Modeling Treatment of Alzheimer's Disease And Mild Cognitive Impairment. Value Health. 2015 Nov;18(7):A698-9. doi: 10.1016/j.jval.2015.09.2608. Epub 2015 Oct 20.  PMID: 26533910

Wonder M, Dunlop S, Chin G, Biggs J, Sullivan SD, Drummond M. Fda Breakthrough Medicines; Have They Caused Breakthrough Headaches for Hta Agencies? Value Health. 2015 Nov;18(7):A550. doi: 10.1016/j.jval.2015.09.1763. Epub 2015 Oct 20.  PMID: 26533088

Chair, thesis committee for Junho Jang
Trends in cost, health status and functional outcomes among adult and pediatric patients with asthma: 2000-2009